Becky McKeirnan Seefeldt
Family · Bradford, PANPI 1346410305
Payments from drug & device makers
Across 100 payments — averaging $17.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$491
- Urovant Sciences Inc$148
- Biohaven Pharmaceutical Holding Company Ltd.$143
- Amgen$107
- Sunovion Pharmaceuticals Inc.$99
- Lilly USA, LLC$85
- plus $694 from 23 others
What the payments were for
- Food & beverage$1,766100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 26 | $491 |
| Urovant Sciences Inc | 9 | $148 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $143 |
| Amgen | 7 | $107 |
| Sunovion Pharmaceuticals Inc. | 6 | $99 |
| Lilly USA, LLC | 5 | $85 |
| AstraZeneca | 4 | $73 |
| Acadia Pharmaceuticals Inc | 4 | $60 |
| Amneal Pharmaceuticals LLC | 3 | $56 |
| Pfizer | 3 | $46 |
| Argenx US, Inc. | 2 | $44 |
| Merck | 2 | $43 |
| Neurocrine Biosciences, Inc. | 2 | $34 |
| Exact Sciences | 2 | $32 |
| Novo Nordisk | 2 | $32 |
| Bristol Myers Squibb | 2 | $30 |
| Biogen | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Abbott | 1 | $21 |
| Neurelis, Inc. | 1 | $20 |
| Banner Life Sciences, LLC | 1 | $20 |
| UCB, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $18 |
| Bayer | 1 | $18 |
| MDD US Operations, LLC | 1 | $18 |
| Dexcom, Inc. | 1 | $18 |
| Mallinckrodt Hospital Products Inc. | 1 | $16 |
| Teleflex LLC | 1 | $16 |
| GSK | 1 | $16 |
How this compares
$1,766 in reported general payments places this provider in the 80th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 14 | $12,082 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $886 |
| Rosuvastatin Calcium | 28 | $530 |
| Omeprazole | 28 | $379 |
| Atorvastatin Calcium | 56 | $262 |
| Escitalopram Oxalate | 16 | $254 |
| Losartan Potassium | 22 | $222 |
| Ezetimibe | 13 | $218 |
| Levothyroxine Sodium | 49 | $217 |
| Amlodipine Besylate | 33 | $194 |
| Metoprolol Succinate | 14 | $164 |
| Gabapentin | 12 | $100 |
| Montelukast Sodium | 11 | $94 |
| Lisinopril | 23 | $85 |
| Metformin Hcl | 13 | $74 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $18 | $12,08214 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $56 | $21749 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,717 family providers in Pennsylvania.
Other family in Bradford
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Jessica LindenbergerPittsburgh$131K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
- Amanda GrippoDickson Cty$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.